GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Techno Medica Co Ltd (TSE:6678) » Definitions » EBIT

Techno Medica Co (TSE:6678) EBIT : 円1,754 Mil (TTM As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Techno Medica Co EBIT?

Techno Medica Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was 円404 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was 円1,754 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Techno Medica Co's annualized ROC % for the quarter that ended in Dec. 2023 was 17.88%. Techno Medica Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 36.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Techno Medica Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 42.04%.


Techno Medica Co EBIT Historical Data

The historical data trend for Techno Medica Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Medica Co EBIT Chart

Techno Medica Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,549.65 1,257.75 1,607.79 1,861.87 1,649.45

Techno Medica Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 377.43 825.52 81.57 442.01 404.46

Competitive Comparison of Techno Medica Co's EBIT

For the Medical Devices subindustry, Techno Medica Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Techno Medica Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Techno Medica Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Techno Medica Co's EV-to-EBIT falls into.



Techno Medica Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,754 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Techno Medica Co  (TSE:6678) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Techno Medica Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=1617.84 * ( 1 - 33.41% )/( (5692.123 + 6360.581)/ 2 )
=1077.319656/6026.352
=17.88 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17815.667 - 1206.401 - ( 10917.143 - max(0, 1997.35 - 15669.114+10917.143))
=5692.123

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15582.431 - 1163.75 - ( 8058.1 - max(0, 2071.367 - 13252.042+8058.1))
=6360.581

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Techno Medica Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1617.84/( ( (1493.652 + max(2754.621, 0)) + (1471.995 + max(3122.575, 0)) )/ 2 )
=1617.84/( ( 4248.273 + 4594.57 )/ 2 )
=1617.84/4421.4215
=36.59 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2087.561 + 2165.596 + 498.814) - (1206.401 + 0 + 790.949)
=2754.621

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2316.193 + 2344.332 + 533.417) - (1163.75 + 0 + 907.617)
=3122.575

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Techno Medica Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=1753.549/4171.064
=42.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Techno Medica Co EBIT Related Terms

Thank you for viewing the detailed overview of Techno Medica Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Techno Medica Co (TSE:6678) Business Description

Traded in Other Exchanges
N/A
Address
5-5-1 Nakamachidai, Tsuzuki-ku, Yokohama, JPN, 224-0041
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.

Techno Medica Co (TSE:6678) Headlines

No Headlines